Growth Hormone Secretagogues · Research deep dive
Tesamorelin: the cited literature
Every study referenced in the Tesamorelin monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, Tesamorelin is studied at 1 mg – 2 mg per administration, typically once daily — commonly 5 days on, 2 off. The reference walkthrough below maps each citation to what it actually showed.
References covered
Effects of tesamorelin on VAT
JAMA, 2007
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for Tesamorelin.